Research Portfolio

Funding Opportunities

Join our Mailing List
Join our mailing list to be notified of new funding opportunities.

Your Email

To receive information about funding opportunities, events, and program updates.

Siva Kolluri, Ph.D.

The Burnham Institute for Medical Research # of Grants: 1


Targeting Hypoxia-inducible Factor to Treat Lung Cancer 2003 (Cycle 12) $509,490
Cancer New Investigator Awards

Mitogenic effect of orphan receptor TR3 and its regulation by MEKK1 in lung cancer cells.
Periodical: Index Medicus:
Authors: Kolluri S, Cao X, Bruey-Sedano N, Lin B, Lin F, Han Y-H, Dawson MI, Zhang XK ART
Yr: Vol: Nbr: Abs: Pg:

Nuclear orphan receptor TR3 targets mitochondria and induces apoptosis through interaction with Bcl-2.
Periodical: Cell Index Medicus:
Authors: Lin B, Kolluri SK, Lin F, Liu W, Cao X, Han Y-h, Dawson M, Reed JC, Zhang X-k ART
Yr: 2004 Vol: 116 Nbr: Abs: Pg: 527-540

The R-enantiomer of the Non-Steroidal Anti-inflammatory Drug Etodolac Binds Retinoid X Receptor and Induces Tumor-selective Apoptosis.
Periodical: Proceedings of the National Academy of Sciences of the United States of America Index Medicus:
Authors: Kolluri, S.K., Maripat Corr, Sharon James, Michele Berasconi Wen Liu, Desheng Lu ART
Yr: 2005 Vol: 102 Nbr: Abs: Pg: 2525 - 2530

Retinoid x receptor regulates Nur 77/TR3-dependent apoptosis by modulating its nuclear export and mitochondrial targeting.
Periodical: Molecular and Cellular Biology Index Medicus:
Authors: Cao, X., liu, W., Lin, F., Li, H., Kolluri, S.k., ART
Yr: 2004 Vol: 24 Nbr: Abs: Pg: 9705 - 9725

Determinants of retinoid X receptor transciptional antagonism.
Periodical: Journal Medical Chemistry Index Medicus:
Authors: Cavasotto CN, Liu G, James SY Hobbs PD, Peterson VJ, Kolluri, SK. ART
Yr: 2004 Vol: 47 Nbr: Abs: Pg: 4360 - 4372